STXBP1 and drug-induced dyskinesia: Although patients with STXBP1-E share prominent common symptoms, including early onset of seizures, dyskinesia, cognitive impairment, and intellectual disability generally without brain structural abnormality, the clinical spectrum of STXBP1-E still expands to include much more extensive neurological disorders [15,16,17].